Virion Therapeutics is a clinical-stage biopharmaceutical company developing T cell-based immunotherapies that utilize genetically encoded checkpoint modifiers to enhance CD8+ T cell responses against virally-associated cancers and chronic infectious diseases. Their approach aims to improve clinical outcomes and survival rates in patients, with ongoing human studies for their lead program targeting chronic HBV.
Funding
Funding not disclosed
Founders
Product
Problem
Current treatments for virally-associated cancers and chronic infectious diseases often fail to elicit a sufficient T cell response, leading to poor clinical outcomes and reduced survival rates. Existing immunotherapies may not adequately stimulate and broaden the CD8+ T cell response needed to effectively target and eliminate infected or cancerous cells.
Solution
Virion Therapeutics is developing T cell-based immunotherapies that utilize genetically encoded checkpoint modifiers (CPM) to enhance and broaden CD8+ T cell responses against virally-associated cancers and chronic infectious diseases. Their VIACT™ platform combines CPMs with intelligently selected and optimized target antigens, inserted into heterologous chimpanzee adenoviral vectors. By genetically encoding checkpoint modifiers, Virion aims to optimize CD8+ T cell responses, leading to improved clinical outcomes and survival. The company's iterative scientific approach is designed to produce adaptable and accessible disease-specific CD8+ T cell-based immunotherapies.
Target Audience
The primary target audience includes patients with virally-associated cancers and chronic infectious diseases, as well as clinicians and researchers seeking novel immunotherapeutic approaches.
Features
- Genetically encoded checkpoint modifiers (CPM) to enhance CD8+ T cell responses
- VIACT™ platform combining CPMs with optimized target antigens
- Heterologous chimpanzee adenoviral vectors for targeted delivery
- Disease-specific CD8+ T cell-based immunotherapies
- First-in-human studies for lead VRON-0200 HBV program